|

[18F]Florbetaben Clinical Trials

6 actively recruiting trials across 3 locations

Also known as: Neuraceq, [18F] Florbetaben

Bethesda, Maryland2 trials

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

National Institutes of Health Clinical Center

Phase 1
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

National Institutes of Health Clinical Center

Phase 1

New York, New York2 trials

Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease

Columbia University Irving Medical Center

Phase 2
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease

Columbia University Irving Medical Center

Phase 2

Other1 trial

Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis
N/A

Kansas City, Kansas1 trial

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

St Luke's Hospital

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.